Pinned Tweet
🩺 Join ASPIRE’s irAE case discussion on Tue, Nov 17, 5:30 PM CT, with Drs. Michael Jain (Moffitt) & Rafeh Naqash (OU), moderated by Drs. Bryan Schneider (UMich) & Lucy Boyce Kennedy (Cleveland Clinic).
CME available 👉 tinyurl.com/u93a98fz
#irAE @MichaelDJain @thenasheffect
👏 Welcome to the newest members of the #irAE Challenging Case Discussion Planning Committee: Dr. Pankti Reid (UChicago, Rheum), Dr. Melissa Lechner (UCLA, Endo) & Dr. Kriti Mittal (UMass, Onc).
@ReidMDMPH @MelissaGLechner @KMittalmd
1
55
ASPIRE Community of Practice retweeted
A passion project of the indomitable #AungNaing, editor-in-chief of @JIPOEditors, was just published! An honor to be part of this ambitious effort discussing barriers and opportunities in ICI therapy today! Authors from @UTMDAnderson @DanaFarberNews @UCSF @BrownUniversity & more
Hot off the press! In this new #JIPO publication, Drs Joud Hajjar, Bettzy Stephen, Aung Naing, and colleagues synthesize key barriers in #ICI therapy and highlight emerging opportunities to refine patient selection, improve safety, and enhance therapeutic durability. Together, these advances position the field to move toward a more precise, effective, and patient-centered era of immuno-oncology.
Note: Journal-based #CME is available for reading this article via InnoScholar.com
Article: doi.org/10.36401/JIPO-26-12
CME activity: innoscholar.com/course/jipo-…
#PositionPaper #ICItherapy #irAEs #immunotherapy #precisiononcology #biomarkers #journalCME
@HajjarJoud
@BettzyStephen
@ajaysheshadri
@kjazieh
@ANaingMD
@SewantiLimaye
@jibranahmed1
@weoncologists
@MDerbalaMD
@mirella_nardo
@ErulEnes
@IMENEHADJI1
@RegmiSunil1
@OncologyNetwork
@Innovativehci
@InnoScholars
@oncodaily
@OncoAlert
Our November @sitcancer special edition 📰newsletter is out!
mailchi.mp/3cf0718a5f0d/f9hi…
Bonus feature: Check out this list of curated abstracts to watch for as you head into the 41st Annual @sitcancer meeting in Phoenix this weekend 🔗⬇️
mailchi.mp/3cf0718a5f0d/f9hi…
🎥 A first for ASPIRE: a patient speaker! In our Sept webinar, Mike shared his irAE journey, Dr. Laura Petrillo (MGB) presented UPLIFT & Dr. Matthias Villalobos (Heidelberg) spoke on shared decision-making. Watch on myConnection 👉 myconnection.asco.org/
#irAE
1
86
ASPIRE Community of Practice retweeted
Congratulations to our team @ASPIRE_CoP for starting this special interest group @sitcancer
See our latest newsletter to learn about the upcoming get together at the annual @sitcancer meeting
Connect with SITC members who share your scientific interests! Explore SITC’s three active Special Interest Groups (SIGs): ASPIRE, Peri-IO Safety and Microbiome. Discover opportunities to network, collaborate and advance cancer immunotherapy. Learn more: sitcancer.org/get-involved/s…
📚 Reading recs from ASPIRE:
• First-line FMT for ICI colitis: ~77% improved, symptoms resolved in a median of 1.5 days
• Recurrent ICI arthritis: the same infl T cells in first and later flares
Links 👉 pubmed.ncbi.nlm.nih.gov/4273…
pubmed.ncbi.nlm.nih.gov/4253…
#irAE #immunotherapy
ASPIRE Community of Practice retweeted
Drs Andrew Trinh and Sophia Ling are fantastic gastroenterology colleagues @PeterMacCC
Thanks so much for helping @NzsOncology put together this free irAE webinar series 🤩 great resource!
@MOGA_ORG @ONCOassist @OncoAlert @ASPIRE_CoP @IndianYoungOnco @oncodaily
The latest of our #NZSOimmunotoxwebinar series is now available online as a FREE resource for any to use and reference! Share widely amongst colleagues 👉nzsoncology.org.nz/webinarse…
🎉 Big news! The new ASPIRE Special Interest Group at #SITC26 holds its first in-person meet-up.
📅 Nov 7, 7:10–7:40 PM at the SITC booth in Phoenix. 🌵
Come connect, share ideas & help build the SIG.
Appetizers & drinks on us! 🍽️
#irAE #immunotherapy
@KMittalmd @sitcancer
ASPIRE, a community of practice of @ASCO is proud to present a virtual webinar on Elevating Patient Voices in the Management of irAEs.
Join us today at 4 pm EST for our Quarterly Webinar series with hosts @KMittalmd and @afreenshariffmd
🔗 in flyer ⬇️
📢 ASPIRE Quarterly Webinar
Elevating Patient Voices & Management of #irAEs
📆 Tues 9/22 · 4:00–5:30 PM ET
🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos
🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd
💻 Zoom🔗: us.list-manage.com/1B14TXB1R…
#Oncology
📢 ASPIRE Quarterly Webinar
Elevating Patient Voices & Management of #irAEs
📆 Tues 9/22 · 4:00–5:30 PM ET
🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos
🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd
💻 Zoom🔗: us.list-manage.com/1B14TXB1R…
#Oncology
Residents & fellows: how are you learning about immune-related adverse events?
⏱️ 5 minutes
🔒 Anonymous
✅ No right or wrong answers
Help ASPIRE's Community Education Committee build better irAE education 👇
🚨 Aug 18: ASPIRE case discussion on immunotherapy toxicity
🧠 Neuro — John Probasco, MD (Hopkins)
🩹 Skin — Silvina Pugliese, MD (NYU)
Moderators: Aliyah Pabani, MD & Stephane Champiat, MD, PhD
5:30–6:30 PM CST | CME 51508
tinyurl.com/yck5afku
#irAE #Oncology
@KMittalmd
ASPIRE Community of Practice retweeted
Replying to @ASPIRE_CoP
@ASPIRE_CoP members please take note!
🚨irAE aficianados! Open comment for Renal, Musculoskeletal, and Cardiac adverse events sections of the @ASCO irAE guidelines are now available through August 28th at:
asco1.qualtrics.com/jfe/form…
As everything with irAE, it's a team sport. We want to hear your comments!
Please share with your trainees- to help us design evidence based education pertaining to irAEs.
cc: @DrKarineTawagi @ASridharMD @NazliDizman @FunchainMD @PGrivasMDPhD
⏰ Starting in 15 minutes!
Join ASPIRE's webinar "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" — 4 PM EST with our expert panel. Hop on 👉 shorturl.at/B2zt2
#irAE #immunotherapy #oncology
2
85
Glad to see some of our Executive Committee members on this- @ASPIRE_CoP remains committed to fostering a community of #irAE clinicians, educators and researchers!
@FunchainMD @thenasheffect
Today's @sitcancer program on immunotherapy toxicity management felt less like a webinar and more like a conversation among colleagues.
#irAEs remain one of the areas where clinical experience is often ahead of the evidence, making discussions like these particularly valuable.
A pleasure to share the session with such a great faculty panel and many friends across the field.
@kreynoldsMD @thenasheffect @EladSharonMD @FunchainMD @LKottschadeCNP Ryan Sullivan, Matthew Lei, Aleksandra Kukla.
Thanks to @sitcancer for the invitation and the discussion!
@Surgeon_General
@CampusBioMedico
@PoliclinCampus

























